Action EVGN EVOGENE LTD.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Evogene Ltd. Nasdaq

Actions

EVGN

IL0011050551

Marché Fermé - Nasdaq
Autres places de cotation
 22:30:00 07/06/2024 		Varia. 5j. Varia. 1 janv.
0,6949 USD +2,19 % Graphique intraday de Evogene Ltd. -6,72 % -17,27 %
23/05 Evogene Ltd. fournit des prévisions de revenus pour l'année 2024 CI
23/05 Transcript : Evogene Ltd., Q1 2024 Earnings Call, May 23, 2024

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Evogene : Immediate Report of Meeting
Evogene : Corporate Presentation
Biomica Presents Positive Clinical Data Update from Ongoing Phase 1 Trial of Microbiome-Based Therapeutic, BMC128, for Refractory RCC, NSCLC & Melanoma - Evogene
Evogene : Biomica Presents Positive Clinical Data Update from Ongoing Phase 1 Trial of Microbiome-Based Therapeutic, BMC128, for Refractory RCC, NSCLC & Melanoma
Earnings Flash (EVGN) EVOGENE Posts Q1 Revenue $4.2M, vs. Street Est of $3.5M
Evogene Reports First Quarter 2024 Financial Results - Evogene
Evogene Ltd. Provides Revenue Guidance for the Year 2024
Evogene : Q1 2024 Consolidated Financial Statements
Evogene: Q1 Earnings Snapshot
Evogene Reports First Quarter 2024 Financial Results
Evogene Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Casterra Announces Additional Agreements with Seed Producers to Meet Existing & Growing Demand for its Elite Castor Seeds - Evogene
Casterra Announces Additional Agreements with Seed Producers to Meet Existing & Growing Demand for its Elite Castor Seeds
Evogene Schedules First Quarter 2024 Financial Results Release - Evogene
Schedules First Quarter 2024 Financial Results Release on May 23, 2024,conference call to discuss the results at 9:00 AM EST
Evogene : 2024 Annual General Meeting of Shareholders
Evogene : Immediate Report of Meeting
Evogene : NOTICE OF 2024 ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON JUNE 6, 2024 - Form 6-K
Biomica to Present at the American Society of Clinical Oncology 2024 Annual Meeting
Biomica to Present at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting - Evogene
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action EVGN
  4. Action EVGN
  5. Actualités Evogene Ltd.
  6. Autres langues